Related Experiment Videos
Cranial CT and MRI in malignant phenylketonuria
F Gudinchet1, P Maeder, R A Meuli
1Department of Radiology, CHUV, Lausanne, Switzerland.
Pediatric Radiology
|January 1, 1992
Summary
Malignant phenylketonuria (PKU), a rare enzyme deficiency, causes hyperphenylalaninemia. MRI findings in PKU patients may aid in monitoring treatment effectiveness.
Area of Science:
- Neurology
- Medical Imaging
- Biochemistry
Background:
- Malignant phenylketonuria (PKU) results from dihydropteridine reductase deficiency.
- This deficiency leads to hyperphenylalaninemia and reduced neurotransmitter levels (DOPA, 5-HTP).
Observation:
- A case study of a malignant PKU patient utilizing CT and MRI is presented.
- CT revealed characteristic basal ganglia calcifications.
- MRI showed T1 hypersignal areas in the basal ganglia, white matter, and cortex, likely representing calcifications.
Findings:
- MRI findings, while not specific, correlate with calcifications observed in CT.
- Hypersignal areas on T1-weighted MRI scans were noted in specific brain regions.
Implications:
- Neuroimaging, particularly MRI, may offer a non-invasive method for assessing treatment efficacy in malignant PKU.
- These findings could guide the monitoring of dietary and neurotransmitter substitution therapies.